Anna Lena Illert
- Molecular Biology
- Epidemiology
- Cell Biology top 10%
- Oncology
- Hematology top 10%
- Co-authors
- Paul SäftigKurt Von FiguraYoshitaka TanakaJudith BlanzEeva‐Liisa EskelinenGünter SchwarzmannJustus DuysterChristian Peschel
- Topics
- Chronic Myeloid Leukemia Treatments (12 papers)Acute Myeloid Leukemia Research (10 papers)Cancer Genomics and Diagnostics (9 papers)
- Cited by
- PhysiologyHematologyCell Biology
- Partner nations
- GermanyUnited StatesAustria
In The Last Decade
Anna Lena Illert
49 papers receiving 817 citations
Peers
Comparison fields: 5 of 87
- Molecular Biology 338
- Epidemiology 231
- Cell Biology 168
- Oncology 131
- Hematology 118
Countries citing papers authored by Anna Lena Illert
This map shows the geographic impact of Anna Lena Illert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Lena Illert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Lena Illert more than expected).
Fields of papers citing papers by Anna Lena Illert
This network shows the impact of papers produced by Anna Lena Illert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Lena Illert. The network helps show where Anna Lena Illert may publish in the future.
Co-authorship network of co-authors of Anna Lena Illert
This figure shows the co-authorship network connecting the top 25 collaborators of Anna Lena Illert. A scholar is included among the top collaborators of Anna Lena Illert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Lena Illert. Anna Lena Illert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 16 | |
| 5 | 0 | |
| 6 | 1 | |
| 7 | 0 | |
| 8 | 0 | |
| 9 | 4 | |
| 10 | 1 | |
| 11 | 10 | |
| 12 | 8 | |
| 13 | 6 | |
| 14 | 4 | |
| 15 | 2 | |
| 16 | 14 | |
| 17 | 11 | |
| 18 | 29 | |
| 19 | 19 | |
| 20 | 23 |
About Anna Lena Illert
Anna Lena Illert is a scholar working on Hematology, Genetics and Oncology, having authored 55 papers that have together received 830 indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (12 papers), Acute Myeloid Leukemia Research (10 papers) and Cancer Genomics and Diagnostics (9 papers). The work is most often cited by research in Physiology (64 citations), Hematology (118 citations) and Cell Biology (168 citations). Anna Lena Illert has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include Paul Säftig, Kurt Von Figura, Yoshitaka Tanaka, Judith Blanz, Eeva‐Liisa Eskelinen, Günter Schwarzmann, Justus Duyster, Christian Peschel, Stefanie Kreutmair and Sivahari Prasad Gorantla. Their work appears in journals such as Journal of Biological Chemistry, Nature Genetics and The Journal of Experimental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.